Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic therapy versus standard care in non-fit acute myeloid leukemia patients
TCTR20150918001Phase 4Recruiting
- Sponsor
- Udon Thani Hospital
- Start
- Mar 2015
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute myeloid leukemia (AML) (2 arms), sponsored by Udon Thani Hospital. Primary endpoint: Overall survival. Started Mar 2015; status: recruiting.
02
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on TCTR20150918001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20150918001.